文献速递母胎医学生殖医学

靶向测序母血游离DNA无创产前诊断cblC缺陷

Noninvasive prenatal diagnosis of cobalamin C (cblC) deficiency through target region sequencing of cell-free DNA in maternal plasma.
PubMed 文献 · Prenat Diagn · 2019-12-26

本研究对21个cblC缺陷家系(含夫妇与先证者)行靶向测序,以三人家系基因型确定亲本致病单体型,再经亲本单体型辅助HMM推断胎儿单体型;无创产前诊断成功推断21例胎儿基因型,经侵入性操作验证一致率100%。

要点

  • 基于单体型分析的无创产前诊断可推断cblC缺陷胎儿基因型。
  • 21例胎儿中检出3例复合杂合、9例杂合携带、9例正常。
  • 无创产前诊断结果经侵入性操作验证一致率为100%。

核心结论

  • 基于单体型分析的无创产前诊断对cblC缺陷具有高一致率,提示其作为高危携带夫妇妊娠诊断方法具有潜在临床实用性。

研究设计与样本

  • 对21个cblC缺陷家系(包括夫妇与先证者)行靶向测序,利用三人家系基因型确定与致病变异连锁的亲本单体型,再通过亲本单体型辅助隐马尔可夫模型(HMM)推断胎儿单体型,并以侵入性操作验证无创产前诊断结果。

主要发现

  • 无创产前诊断成功推断21例胎儿基因型,包括3例cblC缺陷复合杂合子、9例cblC缺陷杂合携带者和9例正常胎儿。
  • 无创产前诊断结果经侵入性操作验证,一致率为100%。

临床怎么用

  • 基于单体型分析的无创产前诊断或可作为高危携带夫妇的妊娠诊断方法,用于推断胎儿cblC缺陷基因型。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to validate the feasibility of haplotype-based noninvasive prenatal diagnosis (NIPD) of cobalamin C (cblC) deficiency. METHOD: This method includes three steps: First, targeted sequencing was performed on 21 families affected by cblC deficiency (including the couples and probands). Second, parental haplotypes linked with the pathogenic variant were determined using the genotypes of trios. Then, the fetal haplotypes were inferred through a parental haplotype assisted hidden Markov model (HMM). The NIPD results were confirmed by using the invasive procedures. RESULTS: Twenty-one fetal genotypes were successfully inferred by NIPD including three compound heterozygotes with cblC deficiency, nine heterozygote carriers of cblC deficiency, and nine normal fetuses. The NIPD results were confirmed using the invasive procedures with 100% concordant rate. CONCLUSION: This result has shown that haplotype-based NIPD of cblC deficiency has high concordant rate and indicated potential clinical utility as a pregnancy diagnosis method for high-risk carrier couples.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Han L, Chen C, Guo F, et al. Noninvasive prenatal diagnosis of cobalamin C (cblC) deficiency through target region sequencing of cell-free DNA in maternal plasma. Prenat Diagn. 2019. PMID: 31697851. doi:10.1002/pd.5601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。